Identification of novel autoantibodies in Sjögren’s disease
Novel autoantibodies will facilitate the diagnosis of Ro/SSA negative patients with SjD, in particular our predictive panel will be useful in the diagnosis and differentiation of these patients from healthy and NSS individuals in a clinical context. In addition, the autoantibodies may also be useful for risk stratification of extraglandular manifestations.
Authors
- Kai Schulze‐Forster (ORCID: https://orcid.org/0009-0008-7297-8717)
- Jacob Ritter (ORCID: https://orcid.org/0000-0001-8962-1564)
- Fiona Engelke (ORCID: https://orcid.org/0000-0002-5673-1705)
- Benjamin Seeliger (ORCID: https://orcid.org/0000-0001-7373-752X)
- Torsten Witte (ORCID: https://orcid.org/0000-0003-4531-0267)
- Petra Budde (ORCID: https://orcid.org/0000-0001-8991-3495)
- Luca Quartuccio (ORCID: https://orcid.org/0000-0002-0134-6439)
- Katja Kniesch
- Thomas Dörner (ORCID: https://orcid.org/0000-0002-6478-7725)
- Annika Loredana Kilian
- Salvatore De Vita (ORCID: https://orcid.org/0000-0002-5066-6076)
- Jan Gras
- Harald Heidecke (ORCID: https://orcid.org/0009-0009-1270-202X)
- Diana Ernst (ORCID: https://orcid.org/0000-0003-0736-6243)
- Hans‐Dieter Zucht
- Ann-Sophie Lindemann
Institutions
- University of Udine (IT)
- Medizinische Hochschule Hannover (DE)
- Institute of Pathology Celle (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-02-03
- DOI
- https://doi.org/10.3389/fimmu.2025.1524940
- Citations
- 5
- Primary Topic
- Salivary Gland Disorders and Functions
- Type
- article
- Field-Weighted Citation Impact
- 5.82
Funders
- Deutsche Forschungsgemeinschaft